Liposomal irinotecan

Liposomal irinotecan, oxaliplatin, and S-1 as first-line therapy for patients with locally advanced or metastatic pancreatic adenocarcinoma (NASOX): A multicenter phase I/IIa study

Jeong H, Kim BJ, Lee CK, Park I, Zang DY, Choi HJ, Lee SS, Park DH, Song TJ, Oh D, Moon SH, Kim KP, Wainberg[...]

By sjmartinez • July 7, 2024